Literature DB >> 16646010

Scanning electron microscopy imaging of dislocations in bulk materials, using electron channeling contrast.

Martin A Crimp1.   

Abstract

The imaging and characterization of dislocations is commonly carried out by thin foil transmission electron microscopy (TEM) using diffraction contrast imaging. However, the thin foil approach is limited by difficult sample preparation, thin foil artifacts, relatively small viewable areas, and constraints on carrying out in situ studies. Electron channeling imaging of electron channeling contrast imaging (ECCI) offers an alternative approach for imaging crystalline defects, including dislocations. Because ECCI is carried out with field emission gun scanning electron microscope (FEG-SEM) using bulk specimens, many of the limitations of TEM thin foil analysis are overcome. This paper outlines the development of electron channeling patterns and channeling imaging to the current state of the art. The experimental parameters and set up necessary to carry out routine channeling imaging are reviewed. A number of examples that illustrate some of the advantages of ECCI over thin foil TEM are presented along with a discussion of some of the limitations on carrying out channeling contrast analysis of defect structures. Copyright (c) 2006 Wiley-Liss, Inc.

Mesh:

Year:  2006        PMID: 16646010     DOI: 10.1002/jemt.20293

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  2 in total

1.  Electron Channeling Contrast Imaging for Rapid III-V Heteroepitaxial Characterization.

Authors:  Julia I Deitz; Santino D Carnevale; Steven A Ringel; David W McComb; Tyler J Grassman
Journal:  J Vis Exp       Date:  2015-07-17       Impact factor: 1.355

2.  Comparison of dislocation characterization by electron channeling contrast imaging and cross-correlation electron backscattered diffraction.

Authors:  Bret E Dunlap; Timothy J Ruggles; David T Fullwood; Brian Jackson; Martin A Crimp
Journal:  Ultramicroscopy       Date:  2017-09-01       Impact factor: 2.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.